• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自修饰的和等排的星形孢菌素苷元库的TrkA激酶抑制剂。

TrkA kinase inhibitors from a library of modified and isosteric Staurosporine aglycone.

作者信息

Tripathy Rabindranath, Angeles Thelma S, Yang Shi X, Mallamo John P

机构信息

Cephalon, Inc., Discovery Research, 145 Brandywine Parkway, West Chester, PA 19380, USA.

出版信息

Bioorg Med Chem Lett. 2008 Jun 15;18(12):3551-5. doi: 10.1016/j.bmcl.2008.05.012. Epub 2008 May 6.

DOI:10.1016/j.bmcl.2008.05.012
PMID:18508265
Abstract

An immobilized Staurosporine aglycone isostere where one of the indole nitrogen atoms was replaced by carbon has been sequentially functionalized to generate compounds inhibiting TrkA kinase. In the first phase, initial screening of a library of C13-hydroxymethyl-7-oxo-indenopyrrolocarbazoles resulted in several potent compounds, one of which was further optimized to generate the corresponding carbamates on solid phase. Some of the major carbamate diastereomers were found to be several-fold more potent than their alcohol parents. Synthesis, SAR analysis, kinase selectivity, and anti-tumor properties of a TrkA inhibitor (12a) are discussed.

摘要

一种固定化的星形孢菌素苷元类似物(其中一个吲哚氮原子被碳取代)已被依次官能化以生成抑制TrkA激酶的化合物。在第一阶段,对C13-羟甲基-7-氧代-茚并吡咯并咔唑文库的初步筛选产生了几种强效化合物,其中一种进一步优化以在固相上生成相应的氨基甲酸酯。发现一些主要的氨基甲酸酯非对映异构体比其醇母体的效力高几倍。讨论了TrkA抑制剂(12a)的合成、构效关系分析、激酶选择性和抗肿瘤特性。

相似文献

1
TrkA kinase inhibitors from a library of modified and isosteric Staurosporine aglycone.来自修饰的和等排的星形孢菌素苷元库的TrkA激酶抑制剂。
Bioorg Med Chem Lett. 2008 Jun 15;18(12):3551-5. doi: 10.1016/j.bmcl.2008.05.012. Epub 2008 May 6.
2
Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles.通过糖基化吲哚咔唑的组合生物合成产生强效和选择性激酶抑制剂。
Chem Commun (Camb). 2009 Jul 21(27):4118-20. doi: 10.1039/b905068j. Epub 2009 May 27.
3
Synthesis, modeling, and in vitro activity of (3'S)-epi-K-252a analogues. Elucidating the stereochemical requirements of the 3'-sugar alcohol on trkA tyrosine kinase activity.(3'S)-表-K-252a类似物的合成、建模及体外活性。阐明3'-糖醇对trkA酪氨酸激酶活性的立体化学要求。
J Med Chem. 2005 Jun 2;48(11):3776-83. doi: 10.1021/jm040178m.
4
Synthesis and biological activities of 4-substituted pyrrolo[2,3-a]carbazole Pim kinase inhibitors.4-取代吡咯并[2,3-a]咔唑 Pim 激酶抑制剂的合成及生物活性。
Eur J Med Chem. 2012 Oct;56:225-36. doi: 10.1016/j.ejmech.2012.08.029. Epub 2012 Aug 30.
5
4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.4-苯胺基-7-吡啶基-3-喹啉甲腈作为Src激酶抑制剂
Bioorg Med Chem Lett. 2009 Sep 1;19(17):5071-4. doi: 10.1016/j.bmcl.2009.07.043. Epub 2009 Jul 10.
6
A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity.一种Cdc7激酶抑制剂可限制DNA复制的起始并具有抗肿瘤活性。
Nat Chem Biol. 2008 Jun;4(6):357-65. doi: 10.1038/nchembio.90. Epub 2008 May 11.
7
Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agent.二氢吡咯并吡唑类转化生长因子-βⅠ型受体激酶结构域抑制剂的优化:发现一种口服生物可利用的转化生长因子-βⅠ型受体抑制剂作为抗肿瘤药物。
J Med Chem. 2008 Apr 10;51(7):2302-6. doi: 10.1021/jm701199p. Epub 2008 Mar 4.
8
Identification of 4-aminopyrazolylpyrimidines as potent inhibitors of Trk kinases.鉴定4-氨基吡唑基嘧啶为Trk激酶的强效抑制剂。
J Med Chem. 2008 Aug 14;51(15):4672-84. doi: 10.1021/jm800343j. Epub 2008 Jul 23.
9
N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors.N-(4-(6,7-二取代喹啉-4-基氧基)-3-氟苯基)-2-氧代-3-苯基咪唑烷-1-甲酰胺:新型双c-Met/VEGFR2受体酪氨酸激酶抑制剂系列
Bioorg Med Chem Lett. 2009 Dec 1;19(23):6552-6. doi: 10.1016/j.bmcl.2009.10.040. Epub 2009 Oct 13.
10
Platinum complex as a nanomolar protein kinase inhibitor.铂络合物作为一种纳摩尔级别的蛋白激酶抑制剂。
Inorg Chem. 2007 Apr 16;46(8):2944-6. doi: 10.1021/ic062055t. Epub 2007 Mar 22.

引用本文的文献

1
Identification of pyrazine-based TrkA inhibitors: design, synthesis, evaluation, and computational modeling studies.基于吡嗪的TrkA抑制剂的鉴定:设计、合成、评估及计算建模研究
Medchemcomm. 2014 Oct 1;5(10):1507-1514. doi: 10.1039/C4MD00251B. Epub 2014 Aug 11.
2
Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors.新型强效TrkA受体酪氨酸激酶抑制剂系列的鉴定
Int J Med Chem. 2012;2012:412614. doi: 10.1155/2012/412614. Epub 2012 May 2.